Kestra Medical Technologies, Ltd. · Healthcare · Medical Instruments & Supplies
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$23.28
−$1.28 (−5.19%) 4:00 PM ET
After hours$23.28
+$0.01 (+0.02%) 8:27 AM ET
Prev closePrevC$24.55
OpenOpen$24.55
Day highHigh$24.67
Day lowLow$22.90
VolumeVol183,110
Avg volAvgVol236,976
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$1.36B
P/E ratio
-5.88
FY Revenue
$74.26M
EPS
-3.96
Gross Margin
46.40%
Sector
Healthcare
AI report sections
BEARISH
KMTS
Kestra Medical Technologies, Ltd.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−19% (Below avg)
Vol/Avg: 0.81×
RSI
41.86(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
-0.01 (Weak)
MACD: 0.08 Signal: 0.09
Short-Term
-0.19 (Weak)
MACD: 0.14 Signal: 0.33
Long-Term
-0.09 (Weak)
MACD: 0.31 Signal: 0.40
Intraday trend score
11.70
LOW2.70HIGH36.00
Latest news
KMTS•6 articles•Positive: 1Neutral: 5Negative: 0
NeutralGlobeNewswire Inc.• Na
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026. The company focuses on transforming patient outcomes in cardiovascular disease through monitoring and therapeutic intervention technologies.
KMTSwearable medical devicedigital healthcarecardiovascular diseaseJ.P. Morgan Healthcare Conferenceinvestor presentation
Sentiment note
The article is primarily informational, announcing a scheduled presentation at a major healthcare conference. There is no discussion of financial performance, product developments, or market challenges. The tone is factual and promotional in nature, neither indicating positive business developments nor negative concerns.
NeutralGlobeNewswire Inc.• Na
Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results
Kestra Medical Technologies will report its second quarter fiscal 2026 financial results on December 11, with a conference call scheduled at 4:30 p.m. Eastern Time. The call will be available via webcast on their investor relations website.
The article is a standard financial reporting announcement with no explicit positive or negative indicators, presenting routine information about an upcoming earnings call
NeutralGlobeNewswire Inc.• Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares
Kestra Medical Technologies is conducting a public offering of 6,000,000 common shares at $23.00 per share, expecting to raise $138 million. The offering includes an option for underwriters to purchase an additional 900,000 shares.
The company is raising capital through a standard public offering, which indicates a strategic financial move to support business growth without signaling significant positive or negative implications
NeutralBenzinga• Globe Newswire
Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares
Kestra Medical Technologies plans to offer 5,500,000 common shares through an underwritten public offering, with potential for an additional 825,000 shares. The proceeds will support sales, marketing, research, development, and general corporate purposes.
The company is conducting a standard public offering to raise capital for business growth and operations, which is a typical financial strategy without strong positive or negative implications
NeutralThe Motley Fool• Motley Fool Markets Team
Kestra Revenue Jumps 52% in Fiscal Q1
Kestra Medical Technologies reported a 52% revenue increase in Q1 FY2026, driven by rising ASSURE wearable defibrillator prescriptions. Despite strong top-line growth, the company experienced widening losses and increased operating expenses.
Mixed performance with strong revenue growth (52%) offset by increased operating expenses and widening net losses. Positive signs include improved gross margin and expanded insurance coverage, but concerns exist about cost management and path to profitability.
PositiveGlobeNewswire Inc.• N/A
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering
Kestra Medical Technologies, Ltd. (KMTS) announced the closing of its upsized initial public offering, raising approximately $202 million. The company's shares began trading on the Nasdaq Global Select Market.
KMTSKestra Medical TechnologiesIPONasdaqwearable medical devicesdigital healthcare
Sentiment note
The company successfully completed its upsized IPO, raising a significant amount of capital, which suggests a positive outlook for the company's growth and development.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal